tert-Butyl ((2-azaspiro[3.3]heptan-6-yl)methyl)carbamate hydrochloride

Catalog No. :
ACITCY831
CAS No. :
2173991-80-3
Molecular Formula :
C12H23ClN2O2
Molecular Weight :
262.78

IUPAC Name:tert-butyl ((2-azaspiro[3.3]heptan-6-yl)methyl)carbamate hydrochloride

tert-Butyl ((2-azaspiro[3.3]heptan-6-yl)methyl)carbamate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$198.00Login to see priceIn stockInquiry
100mg97%$238.00Login to see priceIn stockInquiry
250mg97%$391.00Login to see priceIn stockInquiry
1g97%$988.00Login to see priceIn stockInquiry
5g97%$4595.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl ((2-azaspiro[3.3]heptan-6-yl)methyl)carbamate hydrochloride
IUPAC Nametert-butyl ((2-azaspiro[3.3]heptan-6-yl)methyl)carbamate hydrochloride
MDL No.MFCD31617949
Molecular FormulaC12H23ClN2O2
Molecular Weight262.78
SMILESO=C(OC(C)(C)C)NCC(C1)CC21CNC2.[H]Cl
InChI KeyAVJKEXJXXNZLNL-UHFFFAOYSA-N
Synonymtert-butyl N-({2-azaspiro[3.3]heptan-6-yl}methyl)carbamate hydrochloride;tert-butyl ((2-azaspiro[3.3]heptan-6-yl)methyl)carbamate hydrochloride
CAS No.2173991-80-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACITCY831 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACITCY831 route product structure diagram
    ACITCY8312173991-80-3 In Stock
Inquiry

2. ACITCY831 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACITCY831 route product structure diagram
    ACITCY8312173991-80-3 In Stock
Inquiry

Comments (0)